You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments

 

Online download statistics by month:

Online download statistics by month: August 2022 to February 2026

AbstractFullPdf
Aug 2022337350118
Sep 2022325327138
Oct 202220221046
Nov 202211311423
Dec 2022979715
Jan 202311011117
Feb 2023777927
Mar 2023626419
Apr 202342439
May 202355558
Jun 2023818523
Jul 202342428
Aug 2023595918
Sep 2023606030
Oct 2023646433
Nov 2023818325
Dec 2023727425
Jan 2024393816
Feb 2024545420
Mar 2024767881
Apr 2024666738
May 2024636429
Jun 2024565722
Jul 20249510445
Aug 2024514819
Sep 2024606124
Oct 2024666796
Nov 2024616228
Dec 2024636632
Jan 2025535332
Feb 202512412429
Mar 2025555641
Apr 2025858536
May 2025636438
Jun 2025545530
Jul 2025110
Feb 2026100
Total306531211238